Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Chemotherapy with Bortezomib + Vorinostat for Acute Lymphoblastic Leukemia
Recruiting1 awardPhase 1 & 2
Cleveland, Ohio
This trial tests the effects of adding the drugs bortezomib and vorinostat to chemotherapy for treating infants with acute lymphoblastic leukemia. The drugs may help to decrease the number of leukemia cells, but could also cause additional side effects.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.